Four cases are described of the use of prolonged and/or high doses of adrenaline in the treatment of the low cardiac output syndrome following cardiac surgery. Adrenaline was chosen because it produced a more favourable effect on central cardiovascular haemodynamics and myocardial metabolism when compared with isoprenaline, while its detrimental effects on renal function were less marked than those found when using noradrenaline. The renal insltfficiency encountered was reversed in those cases without previous renal disease. TachYPhylaxis was demonstrated and weaning was achie7)ed by gradual withdrawal of the vasopressor with concomitant blood volume expansion. Two cases with predominant right ventricular failure developed gross ascites and peripheral oedema, making control of fluid balance difficult. These proble11'ls are discussed with a summary of the relevant pharmacology of isoprenaline, noradrenaline, adrenaline and glucagon. The conclusions reached regardinf!, the use and management of adrenaline infusion are given. INTRODCCTIOK 
Four cases are described of the use of prolonged and/or high doses of adrenaline in the treatment of the low cardiac output syndrome following cardiac surgery. Adrenaline was chosen because it produced a more favourable effect on central cardiovascular haemodynamics and myocardial metabolism when compared with isoprenaline, while its detrimental effects on renal function were less marked than those found when using noradrenaline. The renal insltfficiency encountered was reversed in those cases without previous renal disease. TachYPhylaxis was demonstrated and weaning was achie7)ed by gradual withdrawal of the vasopressor with concomitant blood volume expansion. Two cases with predominant right ventricular failure developed gross ascites and peripheral oedema, making control of fluid balance difficult. These proble11'ls are discussed with a summary of the relevant pharmacology of isoprenaline, noradrenaline, adrenaline and glucagon. The conclusions reached regardinf!, the use and management of adrenaline infusion are given. INTRODCCTIOK A low cardiac output state sometimes develops after cardiac surgery. It is characterized by restlessness, peripheral vasoconstriction and cyanosis, hypotension, raised central venous pressure and oliguria (Dietman et al. 1969) . Haemodynamic studies show a reduced cardiac index and a high peripheral vascular resistance; there may be minimal changes in the arterial blood pressure progressing to severe hypotension. :l\Tany preoperative, operative and postoperative factors contribute to the establishment of the syndrome, but fundamentally it is caused bv r~duced myocardial contractile force, while reflex endogenous catecholamine secretion causes the peripheral vasoconstriction.
In the treatment of shock caused primarily by myocardial damage, the maintenance of adequate coronary perfusion and myocardial oxygenation is of such paramount importance that it may be justifiable to temporarily sacrifice perfusion of organs other than the heart and brain to ensure survival and recovery of as much myocardial muscle as possible. In this emphasis on myocardial function, improvement in the cardiac output can be produced (a) by pharmacological stimulation of myocardial con tractility by vasopressors such as isoprenaline, adrenaline, noradrenaline and by glucagon (l\Ioffit, Seslcr and Kirklin 1967) : (b) by optimum blood volume maintenance ; and (c) by rate augmentation by artificial pacing if heart rate is a limiting factor (Litwak, Kuhn and Gadboys 1968) . It is hoped that peripheral perfusion will improve as the increasing cardiac output lessens reflex vasoconstriction. Thus vasopressors are used primarily to stimulate increased myocardial contractility and to improve simultaneously coronary blood flow, if necessary by producing elevation of mean aortic blood pressure by peripheral vasoconstriction.
However, the effect of a particular vasopressor on overall cardiovascular function is determined by its effects on preload, inotropism, afterload and heart rate, which in turn affect cardiac output, coronary blood flow and myocardial oxygen consumption, as well as by its effects on the resistance and capacitance vessels of the circulation. No single agent has a favourable Anaesthesia and Intensive Care, Vol. n, No. J, February, 1974 effect on all these determinants, and so the relative merits of each vasopressor must be considered in making a choice in a particular case.
In shock states caused by loss of blood, plasma or extracellular fluid, vasopressor agents have not been found to produce improvement, but the beneficial haemodynamic effects of vasopressor agents in the management of the low cardiac output syndrome occurring after cardiac surgery has been widely accepted. The responses to the administration of isoprenaline, noradrenaline, adrenaline and glucagon have been studied experimentally in animals (Katz, Hinds and Mills 1969, Finlay, Wrightman and Sykes 1970) and in normal man (Parmley, Glich and Sonnenblich 1968, Dodge, Lord and Sandler 1960) . Clinical investigation of these agents has been carried out in myocardial infarction (Gunner and Loeb 1972, Coffin, Ankeney and Beheler 1966) and after cardiopulmonary bypass (Beregavich, Reicher-Ross and Kunstadt 1971 , Parmley, Matloff and Sonnenblich 1969 . Most authors recommend the use of isoprenaline in postoperative low output states (Harrison, Kerber and Alderman 1970) , but interest in other vasopressors has increased as evidence has been produced that isoprenaline may have disadvantages (Meuller et al. 1968 , Meuller et al. 1970 ).
There are few published reports on the use of adrenaline in the low output syndrome. Most papers describe its use in the experimental situation, usually for very short periods of time (Fordham, Resnekov and Paddle 1968) . Many people consider that patients who become dependant on infusion of high doses of adrenaline cannot survive withdrawal of the drug. This paper presents four successive cases who were successfully weaned from high doses and/or prolonged infusions of adrenaline and of whom three survived to leave hospital. The pertinent pharmacology is reviewed to compare adrenaline with the other agents.
The problems encountered in using high dose infusions of adrenaline are discussed. Some guide-lines for the use of adrenaline in the low cardiac output syndrome are presented.
CASE REPORTS
In two cases the low cardiac output syndrome followed prosthetic valve replacements, and in the other two, followed emergency surgery for complications of acute myocardial infarction. In the coronary care unit of this hospital the pharmacological support used in cases of cardiogenic shock following myocardial infarction is usually a noradrenaline infusion. If refractory to this management, the use of intra-aortic balloon pumping (counterpulsation or LA.B.P.) support may be followed by coronary angiography and surgery on cardiopulmonary bypass. Procedures performed include aortocoronary saphenous vein bypass grafts, infarctectomy, repair of ventricular septal defects and drainage of haemorrhagic cardiac tamponade. In these cases a low output state postoperatively is almost invariable.
Case 1 ( Figure 1) A 48-year-old woman was admitted to the coronary care unit on 9th December, 1972, with a recent myocardial infarct. Four days later, following further severe chest pain, cardiogenic shock developed.
She remained shocked and oliguric for six hours despite -Systolic blood pressure and urine output in Case 1. Following a period of anuria during a noradrenaline infusion, renal function temporarily improved during isoprenaline administration but fell when adrenaline was substituted. Peritoneal dialysis and LA.B.P. were needed to restore urine output to 100 ml per hour or more. digitalization, diuretics, and noradrenaline infusion at 2·5 [Lg/min (1 mg of noradrenaline in 500 ml of 5 per cent dextrose run at 80 microdrops per minute). LA.B.P. was commenced, and this maintained her arterial pressure above 80 mm Hg, with a noradrenaline infusion of 1, 25 [Lg/min. Twelve hours later, when she was still shocked, cardiac catheterization and coronary angiography demonstrated 90 per cent narrowing of the right coronary artery and the circumflex V. 1. CALLAXAN AXD G. A. HARRISON coronary artery. During the procedure acute hypotension occurred. Endotracheal intubation was performed and 1.P.P.V. instituted. An isoprenaline infusion was added to the noradrenaline in an attempt to relieve the intense peripheral vasoconstriction which was present. The noradrenaline was withdrawn over the next few hours while blood volume expansion was achieved with stable plasma protein solution (S.P.P.S.). Surgery revealed the presence of a postero-Iateral infarct and a haemorrhagic pericardial effusion which was drained.
Over the next 12 hours she remained in a hypotensive state with a decreasing urine output, despite mannitol infusion and isoprenaline support. Suspicion of further cardiac tamponade led to re-exploration of her pericardial cavity, but no tamponade was found. During this surgery an adrenaline infusion (10 mg in 500 ml of 5 per cent dextrose) was commenced as isoprenaline was not maintaining an adequate blood pressure nor adequate peripheral perfusion. The infusion commenced at a rate of O·n>ml/min (5 [l.g/min) , but this was trebled to 15 [l.g/min soon after surgery. Despite this, counterpulsation became necessary, and the adrenaline dose was further increased to 22 [l.g/min.
Twenty-four hours after surgery her blood pressure had become stable at 120 mm systolic and her urinary output had improved to 10 ml/hr. The adrenaline was withdrawn as fluids were administered until a dose of 3 [l.g/min was reached, but further reduction in the dose was difficult. Phenylephrine was substituted at a dose of 40 [l.g/min (10 mg of phenylephrine in 500 ml of 5 per cent dextrose at 2 ml/min). Previous experience in the resuscitation of other types of shock had led to the belief that weaning from adrenaline could be achieved sometimes by substitution of phenylephrine, to which less tachyphylaxis occurs, and gradually withdrawing the latter drug. Continued oliguria necessitated institution of peritoneal dialysis three hours later.
Over the next 11 hours the phenylephrine was withdrawn while 2,500 ml of S.P.P.S. was used to maintain left and right atrial pressures. The urine output improved at the same time and peritoneal dialysis was ceased. Counterpulsation support and 1.P.P.V. were slowly withdrawn over the next 60 hours. She subsequently made a good recovery with no evidence of renal impairment.
Summary. Following a myocardial infarct, noradrenaline was used to treat cardiogenic shock but produced intense peripheral vasoconstriction and anuria. Substitution of isoprenaline for noradrenaline was accompanied by a temporarily increased urine output, but severe hypotension developed. Adrenaline was then used for 21 hours to maintain the blood pressure, but anuria persisted. Cessation of vasopressors, and peritoneal dialysis, produced an adequate urine output. I.A.B.P. was necessary for a prolonged period. and mannitol 50 gm improved her circulatory status and urine output. Three bouts of hypotension in the next 12 hours were treated by a temporary increase of the isoprenaline infusion plus blood transfusion with the object of raising the left atrial pressure to 15 mm Hg and the systolic pressure to 100 mm Hg. However, because of right ventricular failure the right atrial pressure rose to levels ::tbove 25 mm Hg at this time. By the next morning she had received 3,500 ml of blood and S.P.P.S., but gross ascites and gross peripheral oedema were present. The urine output was falling but there was no evidence of pulmonary oedema. An infusion containing 1 mg of adrenaline and 5 mg of glucagon in 500 ml of 5 per cent dextrose was run at a rate to maintain a systolic blood pressure above 100 mm Hg as isoprenaline was no longer maintaining the pressure. Initially, the rate was 15 fLg/min. Intravenous frusemide 240 mg was given. A rapid increase in urine output occurred, and was accompanied by the need for an increase in the rate of adrenaline infusion up to 15 fLg/min.
Twenty-four hours after the triple valve replacement her sternotomy was reopened to exclude cardiac tamponade as hypotension with a high right atrial pressure of 18 mm Hg and venous engorgement was present. No tamponade was found; 1,200 ml of ascites was drained to allow improved ventilation.
In an attempt to decrease the volume of crystalloid fluid administered the adrenaline infusion concentration was increased to 40 mg in 500 ml and the infusion rate decreased. However, it soon became necessary to infuse at a rate of 0 ·38 ml/min (32 fLg/min). The degree of dependence on adrenaline at this time was such that cessation of the infusion for 30 seconds to refill the infusion pump syringe caused the systolic blood pressure to fall to below 50 mm Hg. Injection of the adrenaline infusion fluid from a previously filled syringe was used to cover the absence of the infusion at these times. Urine output remained high at all times.
During the next five days the adrenaline was gradually reduced, whilst large volumes of S.P.P.S. (up to 3,000 ml/day) were infused to maintain the left atrial pressure at 15 mm Hg. A vigorous diuresis of greater than 3,500 ml/day was produced by frusemide, to remove the infused fluid, hopefully leaving the colloids in the circulation. Oedema and ascitic fluid decreased but the serum albumin remained below 2 gm per 100 m!. Marked jaundice developed with a serum bilirubin up to 18 mg/100 m!. Adrenaline was ceased on the sixth postoperative day, but 16 hours later it was necessary to use an isoprenaline infusion of 0·2 fLg/min (less than one-hundredth of the dose used in the initial isoprenaline infusion) for a further 48 hours to ensure a good circulation. Diuresis continued without diuretics and a negative fluid balance of 8 litres had occurred in the 10 days following the second operation.
Ventilation was never a problem, although I.P.P.V. with 5 cm Hp of P.E.E.P. was used during the infusion of adrenaline to guard against pulmonary oedema.
The patient made a good recovery and on discharge showed little evidence of renal or hepatic impairment.
Summary. Following a triple heart valve replacement, severe right ventricular failure occurred. Isoprenaline infusion and rapid blood volume expansion were necessary to maintain left ventricular output, but gross peripheral oedema and ascites were produced. The isoprenaline became insufficient to maintain a good circulation, but adrenaline produced a good response. After excluding a cardiac tamponade adrenaline was used for five days to support the circulation. Urine output remained adequate.
Weaning was accompanied by transfusion of large volumes of colloid-containing fluids. 
Case 3
A 63-year-old man suffered a myocardial infarct on 11th February, 1973, and was admitted to hospital in cardiogenic shock. He was digitalized and a noradrenaline infusion (2 mg in 500 ml of 5 per cent dextrose at 0·5 ml/min, i.e. 2 fLg/min) was used to maintain a systolic blood pressure of 100 mm Hg. Frusemide produced a poor diuresis. During the next 24 hours the patient developed a complete heart block, treated by. transvenous pacing, and a diminishing unne output. Pulmonary oedema occurred if noradrenaline was given at a rate to raise the arterial systolic pressure above 90 mm Hg. The blood urea was 101 mgj100 ml. Intra-aortic balloon pUlsation (LA.B.P.) was commenced via the right femoral artery.
The next day the urine output had improved to 50 mljhr but the noradrenaline infusion at 4 (lg/min and the catheter in the right femoral artery produced a cold ischaemic right leg. Coronary angiograms demonstrated disease of three coronary vessels. Three aortocoronary bypass grafts were performed on cardiopulmonary bypass. Extensive infarction of both ventricles was found.
Postoperatively, counterpulsation and noradrenaline infusion were necessary and oliguria persisted for 12 hours. In an effort to improve the circulation in his right leg the LA.B. was removed and adrenaline (40 mg in 500 ml and o . 2 ml/min, i.e. 16 (lg/min) substituted for noradrenaline. The leg became obviously viable and warm, but renal function did not improve in the next two days despite decreased adrenaline dosage after a peak of 25 (lg/min. The blood urea had reached 216 mgjlOO ml.
Peritoneal dialysis was instituted and isoprenaline 20 (lgjmin (25 mg in 400 ml at 0·4 mljmin) used instead of adrenaline. Urine output improved and isoprenaline was decreased over the next three days. Peritoneal dialysis was ceased and adrenaline restarted as isoprenaline was not maintaining the systolic blood pressure at this stage. The urine output remained satisfactory for the ensuing five days while adrenaline at 5-10 (lg/min was used. The concentration of adrenaline in the infusion was reduced slowly from 40 mg in 500 ml of fluid to 4 mg in 500 ml. Occasional ventricular dysrhythmias were controlled by a slow lignocaine infusion.
The cardiovascular status became sufficiently stable to allow cessation of vasopressors, but this was accompanied by a drop in urine output which did not improve despite repeated peritoneal dialysis and isoprenaline infusion. The patient died three days after cessation of dialysis, i.e. 23 days after surgery and nine days after the cessation of adrenaline.
1.P.P.V. was instituted during the angiography and continued until the fourteenth day after admission.
A post-mortem revealed very extensive infarction of both ventricles despite patent aorto-coronary grafts.
The kidneys showed severe ischaemic changes with evidence of previous renal disease.
Summary. After a noradrenaline infusion and LA.B.P. had not controlled the cardiogenic shock after myocardial infarct, aorto-coronary bypass grafts were performed. Post operatively the noradrenaline and the catheter in the femoral artery produced a severely ischaemic leg and a falling urinary output. Substitution of adrenaline improved the leg perfusion, but anuria developed. A later change to isoprenaline was not accompanied by a urine flow until peritoneal dialysis had been instituted. Once the urine flow began, adrenaline did not impair the urine production, and the cardiovascular status was maintained, but withdrawal of the adrenaline produced complete anuna which was refractory to all treatment. Isoprenaline was unable to maintain a ciinicaJlv adequate circulation.
Urine output remaine'd above 80 ml per hour throughout the adrenaline infusion.
Case 4
A 43-year-old male patient underwent replacement of a malfunctioning aortic valve prosthesis on 23rd February, 1973.
Postoperatively, a low cardiac output state developed accompanied by runs of ventricular tachycardia.
An adrenaline infusion was commenced at a rate of 16 fLg/min (20 mg in 500 ml of 5 per cent dextrose at 0·4 ml/min) , but this was rapidly increased to 40 fLg/min (1'0 ml/min) and to 95 fLg/min (2' 0 ml/min) for brief periods to maintain a systolic blood pressure greater than 100 mm Hg. A lignocaine infusion (2 gm in 500 ml 5 per cent dextrose) was run very slowly to control dysrhythmias.
Peripheral circulation and urine output improved rapidly.
During the next 12 hours the adrenaline was administered at 30-40 fLg/min. One run of ventricular tachycardia was reverted by direct current counterstock. An unsuccesful attempt to use an isoprenaline infusion at a rate of up to 20 fLg/min accompanied by volume expansion with S.P.P.S. was made. Isoprenaline did not maintain a satisfactory blood pressure.
Over the next 36 hours gradual reduction in the rate of adrenaline infusion was accompanied by administration of 2,500 ml of S.P.P.S.; frusemide 120 mg/day in divided doses was given to ensure a large urine flow.
Summary. Following prosthetic replacement of the aortic valve, a low cardiac output syndrome was successfully treated with an adrenaline infusion for 48 hours. Improvement in the cardiovascular haemodynamics reversed the oliguria of the shock state. Isoprenaline was unsuccessful in maintaining either the blood pressure or a clinically adequate circulation.
COMPARATIVE CARDIOVASCULAR EFFECTS OF THE VASOPRESSORS

Isoprenaline
The haemodynamic and metabolic effects of isoprenaline are well established. I t is the prototype ~-adrenergic stimulator and produces a rise in cardiac output by a combination of increased heart rate, increased myocardial contractile force, and decreased peripheral resistance. The major contribution is from the positive chronotropic effect (Resnekov, Fordham and Ross 1968), but even after an increase in heart rate by artificial pacing has increased the cardiac index isoprenaline infusion can produce a further increase of 12-20 per cent by inotropic effects (Litwak et al. 1968 ).
The active peripheral vasodilatation accompanied by an increased cardiac output seems to make isoprenaline particularly desirable in the treatment of the low cardiac output syndrome; however, there are other factors which must be considered in its use for this type of case :
(1) The increased oxygen consumption ot the stimulated myocardial muscle is not met by an increase in coronary blood flow of the same order because both diastolic filling time and coronary perfusion pressure fall. A progressive myocardial metabolic acidosis follows as evidenced by decreased lactate utilization or even increasing lactate production (Mueller, Gianelli and Ayres 1968, Mueller et al. 1970 ).
(2) Isoprenaline consistently aggravates arterial hypoxaemia ).
(3) The increase in coronary blood flow produced in normovolaemic subjects will not occur if hypovolaemia is present. The vasodilatation produced by isoprenaline produces a fall in the effective circulating blood volume by promoting pooling in capacitance vessels. The combination of decreased venous return (i.e. preload) and decreased peripheral resistance (i.e. afterload) counteracts the effects of positive inotropism and chronotropism and coronary blood flow will fall unless the vascular bed is well filled. (4) The increased peripheral blood flow occurs mainly through dilated skeletal muscle vessels. The renal vasculature contains no adrenergic receptors mediating vasodilation and may not share in this increased flow as it is " shunted" away from the kidneys (Smith and Corbascic 1970, Goldberg 1968 ). (5) Isoprenaline may not improve urinary output in shock as renal blood flow may not increase (Gunnar et al. 1967 ).
(6) An increased incidence of dysrhythmias accompanies its use in higher doses, thus limiting the maximum effect obtainable (Beregovich et al. 1971) .
Noradrenaline
Noradrenaline produces an increased force of myocardial contraction, and an increased heart rate in the absence of reflex vagal slowing from hypertension.
The predominant peripheral effect is the marked constriction of resistance and capacitance vessels which increases the systolic, diastolic and mean arterial pressures and shifts the circulating blood volume centrally (Eckstein and Abboud 1962, Claus and Ray 1968) . Noradrenaline therefore increases coronary blood flow markedly (Gunnar et al. 1972) but this beneficial effect is offset by several limiting factors:
(1) The marked increase in afterload and reflex cardiac rate slowing may decrease cardiac output despite the stimulation of myocardial contractility. (2) Renal and hepatosplanchnic blood flows are reduced. The oliguria or anuria produced may proceed to renal failure despite withdrawal of the drug. (3) The blood volume squeezed from the capacitance vessels into the central circulation may increase pulmonary capillary pressures sufficiently to precipitate pulmonary oedema (Eckstein et al. 1962 , Claus et al. 1968 ). (4) The plasma volume decreases due to transcapillary exudation of fluid caused by post capillary vasoconstriction and increased capillary pressures. Oedema may result, especially if renal function is concomitantly impaired. Sudden withdrawal of noradrenaline causes an acute increase in the capacity of the circulation. Hypotension follows this sudden relative hypovolaemia (Freeman, Freeman and Miller 1941) . Weaning becomes a serious problem after all but brief usage for this reason.
(5) Tachyphylaxis occurs rapidly, probably due to the effect on the blood volume (Botticelli, Tsagaris and Lange 1965) .
Adrenaline
Adrenaline infusions produce a result which is the algebraic sum of the simultaneous effects of alpha and beta adrenergic stimulation. At low doses the beta adrenergic effects of cardiac stimulation and vasodilation of muscle and hepatosplanchnic circulations predominate. As the dose increases, the alpha receptor mediated vasoconstriction becomes more pronounced in all vascular beds except cerebral and coronary. The increased cardiac output is produced by both enhanced contractile force and increased heart rate. The inotropic effect is dominant in contrast to the dominant chronotropism of isoprenaline, so that for a given increase in heart rate adrenaline produces the larger increase in cardiac output .
The balance of increased contractility, with resultant increased oxygen utilization and increased coronary blood flow, is such that anaerobic metabolism does not occur ). The worsening of arterial hypoxaemia noted with isoprenaline does not characterize adrenaline usage.
As with the previous two pressors, however, there are undesirable effects:
(1) Doses of adrenaline that have minimal effect on mean arterial pressure consistently increase renal vascular resistance and reduce blood flow (Spencer 1956 ) but due to renal autoregulation the effect on urine output is variable. In patients with pre-existing renal disease, low doses may cause oliguria or anuria, while in other patients a good urine output can occur despite high doses.
(2) Shrinkage of plasma volume occurs as with noradrenaline although to a less marked degree in low doses (Freeman et al. 1941 ).
(3) Tachyphylaxis occurs and the problem of withdrawal hypotension is ever-present. (4) High doses tend to produce dysrhythmias.
Glucagon
Glucagon is a polypeptide hormone produced by the alpha cells of the pancreas which as well as its hyperglycaemic effects has been shown to increase the heart rate and force of contraction of the myocardium in animals (Katz et al. 1969, Farah and Tuttle 1960) , and in man (Parmley et al. 1968 , Parmley et al. 1969 . The effects of glucagon on the coronary circulation has been studied in adults and children (Abbott 1972) . It causes significant increases in mean arterial pressure and cardiac output in low flow states, without greatly increasing myocardial oxygen consumption, suggesting that the increased coronary blood flow was sufficient to meet the increased demand for oxygen (Diamond et al. 1970) . No change in peripheral resistance was found and dysrhythmias were not produced.
The findings suggest that glucagon is a valuable adjunct in the treatment of postoperative low output states when given in a dose of 50 [lgjkg half hourly (Van Der Ark and Reynolds 1970). As there is no increased incidence of dysrhythmias, it can be used in conjunction with a catecholamine. Weaning and renal insufficiency are not problems with glucagon.
DISCUSSION
Central Haemodynamics
While isoprenaline is used successfully in the majority of cases, at times it is inadequate to raise the arterial pressure sufficiently to ensure good coronary blood flow. This result of increased myocardial work and a decreased afterload may improve peripheral blood flow, Anaesthesia and Intensive Care, Vol. n, No. 7, February, J.f174 but the increased arterial hypoxaemia and increased anaerobic metabolism in the myocardium extracts a metabolic price from the heart which may exceed any beneficial effects.
After myocardial infarction, maintenance of an adequate blood pressure to ensure coronary perfusion is essential. While noradrenaline does not increase the cardiac index as much as isoprenaline, it does produce a much greater increase in coronary blood flow, while improving myocardial lactate metabolism (Meuller,. et at. 1970 ). This has led many workers to consider noradrenaline as the drug of choice for the treatment of cardiogenic shock after myocardial infarction, despite the oliguria and acidosis which is produced.
Adrenaline also has been shown to produce a favourable change in the balance of oxygen delivery with oxygen consumption in the heart, at least in low doses after cardiac surgery . At low doses (less than 10 fLg/min) adrenaline produces a fall in peripheral resistance and its action is similar to that of isoprenaline, but larger doses produce an increasing peripheral vasoconstriction and the mean blood pressure rises and coronary blood flow continues to increase. At very high doses the action of adrenaline simulates that of noradrenaline. Adrenaline doses can therefore be dictated by the clinical state of a patient. Where only a small rise in cardiac output is needed, a small dose of adrenaline produces myocardial stimulation without increasing peripheral resistance and without producing anaerobic myocardial metabolism. Where a more pronounced effect is desired, adrenaline in a suitably higher dose produced a stronger inotropic effect while raising the blood pressure and ensuring good coronary perfusion. In the extreme case, a high dose produces maximal cardiac stimulation with a raised blood pressure, conditions which ensure the utmost support for the heart at the expense of other organs.
While glucagon has been shown to be effective in reversing a low output state after cardiac surgery, it seems doubtful that it could produce a further increase in myocardiac efficiency once adrenaline had produced its maximum effect. Used in conjunction with a suboptimal dose of catecholamine, it may produce a useful effect.
I t has been pointed out that patients should be kept well hydrated after surgery for myocardial revascularization, and Kluge (1972) has shown that an increase in blood volume will produce definite increases in coronary blood flow. The benefits of a "fluid loading trial" in humans with low cardiac outputs has been established ) and these patients are often best balanced on the verge of pulmonary oedema. This can be done safely if LP.P.V. is used with careful monitoring of atrial pressures and oxygenation.
Peripheral Effects
The impairment of peripheral perfusion caused by noradrenaline and adrenaline compared with isoprenaline was well demonstrated in each of the four cases. In Case 3, the use of adrenaline was associated with improved circulation in a leg rendered ischaemic by noradrenaline. At least in skeletal muscle it appears that vasoconstriction is less marked with adrenaline compared with noradrenaline, when both are used in high doses.
The effect on renal function as expressed by urine output appears to be multifactorial. That both adrenaline and noradrenaline impair renal blood flow is well known; however, the kidney can compensate for a certain degree of this impairment if the blood volume and arterial pressure are near normal levels. An increase in urine flow may occur with the use of noradrenaline or adrenaline when the reversal of the low cardiac output state occurs (Moyer et al. 1955) .
Cases 1 and 3 showed severe renal dysfunction after longer periods of uncorrected low cardiac output accompanied by noradrenaline infusion. Both these factors could be expected to cause ischaemic damage and impair autoregulation before adrenaline was used. Oliguria was not unexpected for that reason. Cases 2 and 4 had rapid restoration of cardiac output and blood pressure and adrenaline infusions did not reduce the urine flow. Even in Case 3, which demonstrated the most severe renal failure, a period of adequate urine output accompanied adrenaline infusion at one stage.
From this it would seem that adrenaline will impair renal function significantly only if preceded by prolonged ischaemia and/or previous renovascular disease.
Isoprenaline does not impair renal function, and may allow restoration of function if its central haemodynamic response is favourable.
OTHER FACTORS OF IMPORTANCE
(a) Fluid Replacement
The need for fluid replacement in cardiac surgical patients must be based on a knowledge of both left and right atrial pressures. The signs of severe right ventricular failure with a Anaesthesia and Intensive Care, Vol. If, No. 1, February, 1974 lesser degree of left-sided failure mimic the signs of cardiac tamponade. Cases 1 and 2 underwent re-exploration of their pericardial cavities to exclude tamponade. Once it was established that severe right-sided failure was present it was necessary to gauge the adequacy of blood volume replacement from the left atrial pressure. In Case 2 a very high right atrial pressure (greater than 30 mm Hg) resulted and gross peripheral oedema and ascites occurred which complicated fluid management.
The maintenance of an adequate colloid osmotic pressure by 5.P.1'.5. is important in these cases as it helps shift the oedema fluid out of the interstitial space into the plasma for clearance in the kidney. The impaired liver production of albumin and losses in ascitic fluid worsen the low serum albumin level.
(b) Respiratory Function
L1'.1'.V. was used in the first three cases throughout the period of vasopressor support. Any tendency to form pulmonary oedema from adrenaline infusion shifting blood into the pulmonary circulation could thus be countered by increasing the intraalveolar pressure. The use of positive-end-expired-pressure (P.E.E.P.) is widely used for this purpose, and was used intermittently in three of the cases presented. If no more than 5 cm of water 1'.E.E.P. was used, then arterial hypotension was not produced. An arterial oxygen tension of not less than 100 mg Hg was maintained for all but brief periods of time.
The fourth case did not have LP.1'.V. during his support with adrenaline and oxygenation was a problem. Four days after withdrawal of the adrenaline worsening respiratory function necessitated tracheostomy and I.P.P.V.
(c) Tachyphylaxis and Weaning
The need for a rapidly increasing dose of adrenaline to maintain a suitable effect was well demonstrated in all four cases. The method of weaning in the presence of a very dependent cardiovascular system depends on the use of time and fluids. Time is necessary to allow the gradual improvement of myocardial function to occur and to allow receptors to slowly regain normal sensitivity to the stimulating drug. Fluids are required to re-expand the blood volume to fill the capacitance vessels dilated by adrenaline withdrawal. The choice of the type of fluid is made after consideration of the haematocrit, serum protein (especially the serum albumin) and serum electrolytes. Whole blood or packed cells transfusion was used to keep the haematocrit above 35 per cent. The serum albumin has been shown to be low in postoperative cardiac surgical patients (Webber and Garrett 1973) and any decrease in hepatic production of albumin worsens this effect, i.e., lowering the plasma colloid osmotic pressure.
Cases 2 and 3 both showed this effect when hypoproteinaemia accompanied gross peripheral oedema. Use was made of large volumes of 5.1'.P.5. during the weaning process, at the same time promoting diuresis with frusemide. This left the albumin in the circulation to increase the colloid osmotic pressure. Electrolyte solutions were used sparingly.
(d) Infusion Pump
Even using microdrip infusion sets, it was our previous experience that smooth control of infusion rates could not be achieved. As the concentration of adrenaline was as high as 40 mg in 500 ml of solution, small variations in drip rates could cause large fluctuations in dosage. Therefore, a constant infusion pump (Harvard Apparatus Co. Inc.) was used and proved satisfactory in allowing smooth control. During weaning a combination of altering the infusion rate and serially diluting the infusion fluid was used. CONCLuSIONS 1. Unless high doses are used, adrenaline may produce a better haemodynamic response than isoprenaline or noradrenaline in terms of increased cardiac output for a given heart rate, increased coronary blood flow, and lessened anaerobic metabolism in the myocardium. The versatility due to changing patterns of response from increasing dose levels makes adrenaline suitable for use in any degree of low cardiac output. In the four cases presented it succeeded in raising the arterial pressure and improving perfusion when isoprenaline had failed.
2. Adrenaline can be used for prolonged periods in high doses without the development of serious dysrhythmias, and in many cases without producing un correctable renal failure.
3. Weaning from high doses of adrenaline is possible if done slowly, and with accompanying re-expansion of the blood volume. 4. 5.P.P.5. should be used as the volume expander during weaning as it helps maintain a normal colloid osmotic pressure and so encourage normal capillary fluid dynamics. This is to help prevent oedema formation.
5.
If oliguria continues during adrenaline infusion despite an adequate blood volume and blood pressure and the use of diuretics, then a trial of isoprenaline should be attempted. If this fails to maintain an adequate haemodynamic response, then adrenaline must be recommenced and the renal function temporarily sacrificed to maintain good cardiac perfusion. 6. Both left and right atrial pressures should be monitored to allow maintenance of an optimal volume and distribution of the circulating blood volume, as rapid central shifts may be produced by adrenaline. These pressures must often be kept at high levels to prevent absolute or relative hypovolaemia, which is the most potent cause of decreased coronary perfusion and cardiac output. 7. A constant infusion pump should be used to allow high concentrations to be delivered at a constant low rate, avoiding excessive fluid volume administration. Adrenaline is preferably infused into a large central vein.
8. Glucagon may be a useful adjunct to low dose adrenaline, but it is doubtful whether any extra response can be obtained when high doses of adrenaline are being used. Since submission of this paper for publication a further nine cases of postoperative low cardiac output have been managed with adrenaline infusions ( Table 1) . The maximum infusion rates ranged from 20 [Lgjmin to 85 [Lgjmin.
Of the nine cases, it was possible to wean six patients off the adrenaline infusion. Two of the six deaths recorded were from causes unrelated to the adrenaline infusion (Cases 5 and 8). A further three cases (Nos. 10, 11 and 13) were not considered salvageable, but adrenaline infusion may have contributed to their death.
These results reflect the poor prognosis obtained from any form of treatment for cardiogenic shock following myocardial infarction. In this series valve replacement surgery, even with severe low output states, did not appear to be attended by the high mortality encountered in the other two groups of surgical procedures.
